Chinese Journal of Dermatology ›› 2014, Vol. 47 ›› Issue (1): 30-32.

• Original articles • Previous Articles     Next Articles

Determination of coagulation status as well as circulating levels of complement and inflammation markers in patients with chronic urticaria during acute attack and in remission stage

  

  • Received:2013-01-21 Revised:2013-03-10 Online:2014-01-15 Published:2014-01-01
  • Contact: huilan zhu E-mail:zhlhuilan@126.com

Abstract: Liang Bihua, Li Runxiang, Lin Luyang, Li Zhenjie, Xiao Changqing, Zhu Huilan. Guangzhou Institute of Dermatology and Venereology, Guangzhou 510095, China Corresponding author: Zhu Huilan, Email: zhlhuilan@hotmail.com 【Abstract】 Objective To determine the coagulation status as well as circulating levels of complement and inflammation markers in patients with chronic urticaria (CU) during acute attack and in remission, and to estimate the relationship of coagulant and anticoagulant factors as well as fibrinolytic markers with the development of chronic urticaira. Methods This study included 40 patients with CU (22 during acute attack and 18 in remission) and 40 healthy blood donors from the Guangzhou Blood Center. Venous blood samples were obtained from these subjects, and enzyme-linked immunosorbent assay (ELISA) was performed to measure the plasma levels of prothrombin fragment 1+2 (F1+2), tissue factor (TF), thrombomodulin (TM), high molecular weight kininogen (HMWK), tissue-type plasminogen activator (t-PA), C5a and serum levels of C3, C4, antistreptolysin O antibodies(ASO), rheumatoid factor (RF) and C-reactive protein (CRP). Erythrocyte sedimentation rate (ESR) was also determined in these patients. Comparisons of these parameters were carried out by using t test, and the correlation of these factors with CU was evaluated by using Spearman correlation coefficient. Results Compared with the healthy controls, the patients with CU showed significantly higher plasma levels of F1+2 and HMWK (both P < 0.01), but lower levels of TF, TM and t-PA(all P < 0.01). The plasma levels of F1+2, HMWK, t-PA were significantly correlated with the symptom scores in patients with CU (r = 0.81, P < 0.01; r = -0.39, P < 0.05; r = 0.35, P < 0.05). A significant increase was observed in the plasma concentration of F1+2 in patients during acute attack compared with those in remission (P < 0.01), whereas no significant differences were noted in the plasma levels of TF, TM, HMWK, t-PA, C5a, serum levels of C3, C4, ASO, RF and CRP or ESR between the two groups of patients (all P > 0.05). Conclusions It seems that coagulation, anti-coagulation and fibrinolysis are all involved in the development of urticaria. There is an obvious difference in the plasma level of prothrombin F1+2 between patients with CU during acute attack and in remission, suggesting that coagulation factors play a certain role in the initiation and progression of CU.

Key words: Urticaria, Blood coagulation, Complement system proteins, Inflammation

share this article